Budesonide for prevention of irinotecan (CPT-11)-induced diarrhea. Results of a double-blind, placebo-controlled, multicenter, randomized phase-III-study in patients with advanced colorectal cancer (CRC). 30. Mai 2003 Karthaus, M., Ballo, H., Steinmetz, T., Geer, T., Schimke, J., Braumann, D., Behrens, R., Kindler, M., Greinwald, R., Kleeberg, U., 2003. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Scheithauer, W., McKendrick, J., Begbie, S., Borner, M., Burns, W.I., Burris, H.A., Cassidy, J., Jodrell, D., Koralewski, P., Levine, E.L., Marschner, N., Maroun, J., Garcia-Alfonso,… Weiterlesen